Ganymed Robotics

Ganymed Robotics is a medical robotics company that develops AI-powered surgical robotic assistants for orthopedic surgery, specifically focused on knee replacement procedures. The company combines advanced computer vision, artificial intelligence, and robotic arm technology to help surgeons perform more precise and effective orthopedic surgeries. Ganymed's technology features marker-less robotics, enabling the system to track and assist surgical procedures without requiring physical markers or fiducials placed on the patient, simplifying surgical workflow and reducing setup time. The company has announced a breakthrough in marker-less robotics for patients undergoing knee replacement surgery, representing a significant advancement in the field of computer-assisted orthopedic surgery. The product is currently in pre-clinical testing and has not yet received FDA clearance or regulatory approval for commercial sale. Founded in 2018 and headquartered in Paris, France, Ganymed Robotics has raised approximately $38.1 million in Series B funding from investors including EIT Health, Cathay Capital, Credit Mutuel Equity, Kurma Partners, BNP Paribas Developpement, Caphorn, EIC Fund, Bpifrance, and Europa, with a team of 30 employees.